TON - September 2013 Vol 6 No 8

TON - September 2013 Vol 6 No 8 — September 23, 2013
Promising results were obtained with enzalutamide monotherapy in patients with hormone-naive prostate cancer. Read More ›

TON - September 2013 Vol 6 No 8 — September 23, 2013
A novel fixed-dose combination of netupitant and palonosetron, referred to as NEPA, was found to be highly effective in preventing chemotherapy-induced nausea and vomiting in 2 studies presented at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting. Read More ›

Page 2 of 2


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: